Drugs & Targets BioNTech, Autolus form CAR T-cell therapy collaboration to advance pipeline and expand late-stage programs February 16, 2024Vol.50 No.07
Drugs & Targets Friends of Cancer Research initiates Digital PATH research partnership February 09, 2024Vol.50 No.06
Drugs & Targets European Commission authorizes Omjjara in anemia indication February 02, 2024Vol.50 No.05
Drugs & Targets FDA approves Balversa for locally advanced or metastatic urothelial carcinoma January 26, 2024Vol.50 No.04
Drugs & Targets FDA approves Keytruda + chemoradiotherapy for FIGO 2014 stage 3-4A cervical cancer January 19, 2024Vol.50 No.03
Drugs & Targets U.S. Patent Office grants patent for ATOR-4066 bispecific antibody cancer treatment January 19, 2024Vol.50 No.03
Drugs & Targets Caris, Flatiron partner to create real-world data offering January 12, 2024Vol.50 No.02
